首页 | 本学科首页   官方微博 | 高级检索  
     

多药耐药相关蛋白7及其抑制剂
引用本文:代景莹. 多药耐药相关蛋白7及其抑制剂[J]. 国际肿瘤学杂志, 2010, 37(11). DOI: 10.3760/cma.j.issn.1673-422X.2010.11.007
作者姓名:代景莹
作者单位:东南大学医学院附属中大医院血液内科,南京,210000
基金项目:国家自然基金资助项目,高等学校博士学科点专项科研基金 
摘    要:多药耐药(MDR)的机制与转运蛋白有关,现在研究最多的为P-糖蛋白(P-gp)、多药耐药相关蛋白(MRP)1、乳腺癌耐药相关蛋白(BCRP)等的抑制剂.MRP7可介导对紫杉醇、长春新碱和长春碱等的耐药.MRP7抑制剂近年研究主要包括千斤藤素、酪氨酸酶抑制剂、环孢素A等,MDR是多种机制共同作用的结果,对其他转运体的研究会提供更全面、更广泛的MDR逆转途径.

关 键 词:抗药性,肿瘤  多药耐药相关蛋白  多药耐药相关蛋白7抑制剂

Multidrug resistance associated protein 7 and its inhibitors
DAI Jing-ying. Multidrug resistance associated protein 7 and its inhibitors[J]. Journal of International Oncology, 2010, 37(11). DOI: 10.3760/cma.j.issn.1673-422X.2010.11.007
Authors:DAI Jing-ying
Abstract:Mechanism of reversing multidrug resistance (MDR) is associated with transport proteins.Up to date, researches mainly concern P-glycoprotein (P-gp) multidrug resistance associated protein 1(MRP1), breast cancer resistance protein (BCRP) inhibitors. Multidrug resistance associated protein 7(MRP7) is one of ABC transporters ,which belongs to multidrug resistance associated protein (MRP) subfamily. A certain number of studies have been conducted in recent years about it , however , they are relatively less than studies on P-GP,MRP1 and BCRP, et al. Structure of MRP7 has certain differences compared with that of other MRPs,and MRP7 mediates drug resistance to paclitaxel,vincristine,taxanes,etc. In recent years reported inhibitors include cepharanthine tyrosine kinase inhibitors、cyclosporine A,et al. MDR results from a variety of mechanisms so that researches on other transporters may provide extensive ways to reverse MDR.
Keywords:Drug resistance,neoplasm  Multidrug resistance associated proteins  Multidrug resistance associated protein 7 inhibitors
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号